Research and Clinical Trials

Short-course hypofractionated proton beam therapy incorporating advanced imaging may improve overall survival over standard radiation therapy in people over 65 with grade 4 malignant glioblastoma.

Daratumumab, a monoclonal antibody drug, significantly reduces the risk of progression to active multiple myeloma and improves overall survival compared to active monitoring.

Study demonstrates potentially effective treatment for people with bladder cancer who no longer respond to Bacillus Calmette-Guérin (BCG).

An overview of the 10 most popular articles Mayo Clinic Comprehensive Cancer Center Blog published in 2024.

Mayo Clinic Comprehensive Cancer Center researchers spent 2024 mining patient data, leveraging artificial intelligence and conducting clinical trials to reveal insights that improve patient care.

Researchers have developed an innovative mesothelioma testing strategy that could potentially increase the detection rate of cancer DNA in the blood.

Enhancing digital literacy and improving access to the internet and digital devices may make it easier for rural smokers to quit.

Dr. Michael Wallace, a Mayo Clinic interventional endoscopist, discusses pancreatic cancer screening and research advancements.

Dr. Keith Knutson discusses lung cancer vaccine research at Mayo Clinic and how physicians might use vaccines for other types of cancer.

Read about the research being conducted to improve CAR-T cell therapy and expand its capabilities to treat more conditions.